ALUR Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 3.14%, SMA50 -11.29%, SMA200 -39.14%). The stock’s 14-day RSI is 48.43 (neutral), while the ATR of 0.23 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -70.1% below its high and over 31.58% above its low. Average 10-day trading volume of 69.42 thousand shares is below the 3-month average of 2.79 million, indicating normal recent market interest.

Allurion Technologies Inc. has 14.99 million shares outstanding. The public float is 8.81 million shares, elevated short interest at 5.17% of float. This equals 475.73 thousand shares. The short ratio is 4.91 days. Institutional investors hold 76.99% of the float. Insiders own 8.45%. Over the past six months, insider transactions show net selling. They sold 3.21 thousand shares across 2 transactions.

Allurion Technologies Inc. generated EPS of -$7.33 over the past year. Five-year average earnings growth is -618.79%. Wall Street analysts project EPS growth of 52.56% annually over the next five years. Analyst sentiment is neutral. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 1 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $3.00 to $2.50. The high target offers 252.94% upside. The low target suggests 194.12% downside. The mean target is $2.75. This offers 223.53% upside. Allurion Technologies Inc. earnings surprise history is a mixed track record. The quarter that ended May 20, 2026, missed forecasts by 35.29%. The prior quarter beat by 35.29%. Over the last six quarters, Apple has recorded several small beats. These include -128.1% in May 14, 2025.

Allurion Technologies Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.25. This means the shares are trading below this model’s fair value.

Allurion Technologies Inc. (OTC:ALUR) closed at $0.85 USD, losing -$0.06 (-6.48%) from the previous close of $0.91. The stock is currently mid-range between its 52-week high and low $0.23 and $3.33. With a market capitalization of about $6.42 million, Allurion Technologies Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.18). Key stats such as the average daily volume over the past year has been around 2.67 million shares, volume is running light vs its 52-week average. Headquartered in Natick, MA, Allurion Technologies Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Shantanu K. Gaur, the company employs approximately 134 people and listed since March 29, 2021. Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight.

Allurion Technologies Inc. trades at a P/E ratio of -3.6, slightly below the S&P 500 average, with a price-to-sales ratio of 0.54 and a price-to-book ratio of -1.54 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.3, also above market averages.

Our AI price prediction model suggests that Allurion Technologies Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.23%, with price expected at $0.87 by June 02, 2026, within a range of $0.80 to $0.95 3-Month Outlook: Projected fall of -58.87%, reaching $0.35 by August 17, 2026, with a range of $0.09 to $0.55. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by May 19, 2027, within a range of $0.00 to $2.23.

Allurion Technologies Inc. (NYSE:ALUR) shares are up 30.08% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Allurion Technologies Inc. trading at a premium to the broader market with a P/E of -3.6. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $4.43, suggesting 420.56% upside. Our AI forecast model points to short-term strength (2.23% over two weeks), a medium-term fall (-58.87% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.